Oxybee
oxalic acid dehydrate
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for Oxybee. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Oxybee.
For practical information about using Oxybee, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.
Authorisation details
Product details | |
---|---|
Name |
Oxybee
|
Agency product number |
EMEA/V/C/004296
|
Active substance |
oxalic acid dihydrate
|
International non-proprietary name (INN) or common name |
oxalic acid dehydrate
|
Species |
Bees
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QP53AG03
|
Publication details | |
---|---|
Marketing-authorisation holder |
Dany Bienenwohl GmbH
|
Revision |
0
|
Date of issue of marketing authorisation valid throughout the European Union |
01/02/2018
|
Contact address |
Geyerspergerstrasse 27
80689 Munich Germany |
Product information
01/02/2018 Oxybee - EMEA/V/C/004296 -
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Ectoparasiticides for topical use, incl. insecticides
Therapeutic indication
For the treatment of varroosis (Varroa destructor) of honey bees (Apis mellifera) in brood-free colonies.